Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Fatigue
ADR ID BADD_A01626
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.002      Fatigue
Description A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities. [CTCAE] The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. [MeSH]
MedDRA Code 10016256
MeSH ID D005221
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Enervation | Exhaustion | Exhaustion due to excessive exertion | Exhaustion due to exposure | Fatigability | Fatigability generalized | Fatigability lumbar | Fatigability of knees | Fatigue | Fatigue extreme | Fatiguability | Lassitude | Loss physical strength | Prostration | TATT | Tired all the time | Tired and heavy | Tired out | Tiredness | Washed-out | Weariness | Worn out | Fatigue aggravated | Depressive weariness | Fatigueability generalised | Chronic fatigue | Fatiguability generalised
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02294Trimipramine--
BADD_D02295Trimipramine maleate--
BADD_D02297Triptorelin--
BADD_D02298Triptorelin pamoate--
BADD_D02301Troglitazone--
BADD_D02303Tropicamide--
BADD_D02304Tropisetron--
BADD_D02305Trospium--
BADD_D02306Trospium chloride--
BADD_D02307Trovafloxacin--
BADD_D02308Trovafloxacin mesylate--
BADD_D02309Troxerutin--
BADD_D02312Ulipristal--
BADD_D02313Ulipristal acetate--
BADD_D02319Urofollitropin--
BADD_D02321Ursodiol--
BADD_D02322Ustekinumab--
BADD_D02323Valacyclovir--
BADD_D02324Valacyclovir hydrochloride--
BADD_D02325Valdecoxib--
BADD_D02326Valganciclovir--
BADD_D02327Valganciclovir hydrochloride--
BADD_D02329Valproic acid--
BADD_D02331Valsartan--
BADD_D02332Vancomycin--
BADD_D02334Vandetanib0.001948%
BADD_D02337Varenicline--
BADD_D02338Varenicline tartrate--
BADD_D02342Vedolizumab--
BADD_D02343Velaglucerase alfa--
The 36th Page    First    Pre   36 37 38 39 40    Next   Last    Total 40 Pages
ADReCS-Target
ADR Term Drug Name Target